Background {#s1}
==========

Insulin resistance in type 2 diabetes and related issues are known \[[@R01]\]. Symptoms associated with the disease include retinopathy, edema, micro aneurysms, nephropathy outlines, symmetrical fringe neuropathy influencing engine and tactile nerves of the smaller attachments \[[@R02]-[@R04]\]. Several models of treatments using insulin, secretagogues (sulfonylureas and incretins) and hypoglycemias (biguanides, thiazolidinediones and a-glucosidase inhibitors) are currently available \[[@R05]-[@R10]\]. Inhibitors of the dipeptidyl peptidase-4 (DPP-4) are linked with the activities of GLP-1 and gastric inhibitory polypeptide (GIP) \[[@R07],[@R08]\]. Description of the structural models for DPP-4 is known \[[@R15]-[@R17]\]. Therefore, it is of interest to identify molecules to inhibit DPP-4 using molecular docking analysis.

Materials and Methods: {#s2}
======================

Sequence to structure modeling and docking analysis of DPP-4: {#s2a}
-------------------------------------------------------------

The DPP-4 protein sequence downloaded from GenBank was analyzed in a comprehensive using tools such as Clustal Omega, Pfam, Prosite, SMART, PANTHER, PHYLIP, STRING and InterProScan, molecular docking and ligand-protein analysis tools to glean valuable insights \[[@R11]-[@R21]\].

Results and discussion: {#s3}
=======================

A comprehensive analysis of DDP-4 using sequence and structure information is highly relevant in the fight against T2DM with reference to known data in the literature. The Multiple Sequence Analysis (MSA) of DDP-4 from different organisms such as Homo sapiens (DPP4, 766 amino acid), Rattus norvegicus (DPP4, 767 amino acid), Mus musculus (DPP4, 760 amino acid), Danio rerio (DPP4, 750 amino acid) and Gallus gallus (DPP4, 760 amino acid) is given in [Figure 1](#F1){ref-type="fig"}. Secondary structure information of DDP-4 is also shown in [Figure 1](#F1){ref-type="fig"}. Domain and phylogeny analysis of DDP-4 in different organisms is given in [Figure 2](#F2){ref-type="fig"}.The Secondary structure analysis of human DDP-4 along with small nonpolar, hydrophobic, polar, and aromatic plus cysteine residues in human DDP-4 is shown in [Figure 3](#F3){ref-type="fig"}. Protein-protein interaction network linked to DDP-4 is shown in [Figure 4](#F4){ref-type="fig"}. We further show the DDP-4 associated pathways in [Figure 5](#F5){ref-type="fig"}. The molecular docking interaction of DPP4 with STOCK1N-98884 is given in [Figure 6](#F6){ref-type="fig"} and [Table 1](#T1){ref-type="table"}-[Table 4](#T4){ref-type="table"}. This information gleaned from the analysis of DDP-4 is relevant in the design and development of novel compounds in combating the disease.

Conclusions: {#s4}
============

We document compounds STOCK1N-98884, STOCK1N-98881, and STOCK1N-98866 from the IBS ligand database with optimal binding features with DPP-4 towards combating T2DM.
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###### Lowest binding energy for the Ligands-Protein interaction, along with scores for various interaction types, as detected by GLIDE GScore; Glide extra precision scores (kcal/mol) Lipophilic E Vdw; Chemscore lipophilic pair term and fraction of the total protein--ligand vdw energy HBond; Hydrogen-bonding term

  Compounds ID                                                                                                                                      Binding Energy MM-GBSA (kcal/mol)   GScore   Lipophilic E vdw   H-bond   Electro   Protein ligands interaction
  ------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------- -------- ------------------ -------- --------- ---------------------------------------------------------
  STOCK1N-98884                                                                                                                                     -72.7837                            -11.56   -2.91              -6.87    -2.01     Glu:205, Glu:206, Try :547, Ser:630 and Asn710
  STOCK1N-98881                                                                                                                                     -61.2792                            -10.2    -3.37              -4.44    -2.41     Arg:125, Glu:205, Glu:206, Lys:554, Trp:629 and Ser:630
  STOCK1N-98866                                                                                                                                     -59.2571                            -9.58    -2.46              -3.65    -3.19     Arg:125, Try :547, Lys:554 and Trp:629
  Known Inhibitor                                                                                                                                                                                                                      
  Linagliptin                                                                                                                                       -44.1282                            -6.79    -2.22              -2.61    -0.34     Try :547, Ser:630 and Asn710
  Electro; Electrostatic rewards Protein ligands interaction; p--p stacking, p--cat interaction and hydrogen bond between the ligands and protein                                                                                      

###### Evaluation of drug-like properties of the lead molecules by Qikprop Maestro 10.5 molecular docking suite

  Molecule                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   QPlog Po/w (-2.0 to 6.5)   Q P log HERG (acceptable ange:above -5.0)   QPP Caco (nm/s)\<25---poor\>500---great   Q P log,BB(-3 to 1.2)   QPP MDCK (nm/s)   Q Plog Kp (-8.0 to -0.1)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------- ------------------------------------------- ----------------------------------------- ----------------------- ----------------- --------------------------
  STOCK1N-98884                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              -0.3                       -1.056                                      131.328                                   -0.94                   70.119            -2.798
  STOCK1N-98881                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              3.376                      -0.015                                      283.926                                   -0.628                  485.3             -2.406
  STOCK1N-98866                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              2.219                      -3.804                                      143.431                                   -1.641                  60.643            -3.179
  Predicted IC50 value for blockage of HERG K+ channels; (acceptable range above -5.0) Molecule STOCK, InterBioScreen's library (IBS), Q P log Poct; was predicted partition coefficient of octanol/gas, (8.0 to 35.0); QPP Caco, predicted apparent Caco-2 cell permeability in nm/s. Caco-2 cells is a model for the gut blood barrier (nm/s) \<25-poor, \>500-great. Q P log BB, predicted brain/blood partition coefficient; QPP MDCK, predicted apparent MDCK cell permeability in nm/s. MDCK cells are considered to be a good mimic for the blood--brain barrier; (nm/s) \<25-poor, \>500-great; Q P log KP, Predicted skin permeability; Q P log Khsa Prediction of binding to human serum albumin; (acceptable range -1.5 to 1.5)                                                                                                                                                              

###### Boiled egg parameters

  Molecule        MW       TPSA     XLOGP3   MLOGP   GI absorption   BBB permeant
  --------------- -------- -------- -------- ------- --------------- --------------
  STOCK1N-98884   430.88   159.85   -0.3     -0.66   High            No
  STOCK1N-98881   624.04   158.3    2.99     0.23    Low             No
  STOCK1N-98866   421.4    127.08   2.81     0.93    High            No

###### Biological activity spectrum of compounds (Pa -- Active; Pi -- Inactive)

  Molecule        Pa      Pi      Activity
  --------------- ------- ------- ---------------
  STOCK1N-98884   1.219   0.449   Anti-diabetic
  STOCK1N-98881   1.812   0.642   Anti-diabetic
  STOCK1N-98866   1.121   0.318   Anti-diabetic

![(A) MSA of DDP-4 from different organisms (Homo sapiens, Rattus norvegicus, Mus musculus, Danio rerio and Gallus gallus) (B) Secondary structure information on DDP-4](97320630016444F1){#F1}

![Domain and phylogeny analysis of DDP-4 in different organisms](97320630016444F2){#F2}

![(A) Secondary structure analysis of human DDP-4 (Homo sapiens). (B) Small non-polar, hydrophobic, polar and aromatic plus cysteine residues in human DDP-4.](97320630016444F3){#F3}

![(A) Interacting proteins with DPP4 using STRING v10.database. (B) Explanation of interactions shown.](97320630016444F4){#F4}

![DDP-4 linked pathways.](97320630016444F5){#F5}

![(A) Molecular docking interaction of DPP4 with STOCK1N-98884. (B) Cartoon interpretation of DPP4 with compound STOCK1N-98884. (C) Boiled-egg plot.](97320630016444F6){#F6}
